Alexandria, Virginia (August 12, 2020) The Global Business Travel Association (GBTA) – the world’s largest professional association – hosted well-regarded futurist and trendcaster Dr. Shawn DuBravac for the first webinar in its GBTA Collaboratory 2020 series. DuBravac shared his insights on the path to pandemic recovery for the global travel industry. DuBravac joined GBTA Interim-Executive…
GBTA Collaboratory 2020 The GBTA Collaboratory launched yesterday with an insightful discussion between GBTA Interim Executive Director, Dave Hilfman and President, Avrio Institute, Dr. Shawn DuBravac regarding the economics of the business travel recovery. The Collaboratory webinar series will continue over the next 10-weeks and will provide global perspectives, best practices, expert insight, and actionable…
“Business travel recovery will be uneven, with innovative and creative companies taking the lead” was just one of the many key takeaways from trendcaster Dr. Shawn DuBravac when he joined GBTA Interim Executive Director Dave Hilfman on the first webinar of the Collaboratory. DuBravac and Hilfman discussed the current state of travel and what the…
Calls on Congress to Take Action on Expanded Relief for Distressed Business Travel Industry As the US Congress negotiates a new coronavirus relief package for individuals and businesses, the Global Business Travel Association (GBTA) – the leading voice of business travel worldwide – has called on Congressional leadership to enact measures to renew business travelers’…
Congressional Call to Action – ACT NOW to Support Travel Congress and the Administration are again at loggerheads on how to address the Coronavirus epidemic. The reports today are that congressional action is in doubt. The Cares Act we helped to pass in May was about stabilizing the travel industry. This time we need Congress…
COVID Vaccine Tracker: When Will We Have a Coronavirus Vaccine? Researchers around the world are racing to develop a vaccine against Covid-19, with more than 140 candidate vaccines now tracked by the World Health Organization (WHO). Vaccines normally require years of testing and additional time to produce at scale, but scientists are hoping to develop…
Lobbying for Business Travelers in D.C. Takes on New Challenges These Days There’s no silver bullet for fixing the fallout from the pandemic, a leading corporate travel lobbyist has warned. Having ensured the “four pillars of travel” — namely airlines, agencies, hotels and ground transportation firms — were represented during the creation of the $2.2…
Alexandria, VA – As the U.S. Congress negotiates a new coronavirus relief package for individuals and businesses, the Global Business Travel Association (GBTA) – the leading voice of business travel worldwide – has called on Congressional leadership to enact measures to renew business travelers’ confidence and to curb the devastating impact of the pandemic on…
GBTA Calls on Congress to Take Action on Expanded Relief for Distressed Business Travel Industry Group requests expanded COVID-19 testing and SBA relief funding to restore the health of the $1.4 trillion business travel industry As the U.S. Congress negotiates a new coronavirus relief package for individuals and businesses, GBTA has called on Congressional leadership…
U.S. Reaches $2.1 Billion Deal with Sanofi, GlaxoSmithKline for COVID-19 Vaccine Push The federal government has reached a deal worth up to $2.1 billion with drugmakers Sanofi and GlaxoSmithKline as part of Operation Warp Speed, the Trump administration’s push to have a coronavirus vaccine widely available by early 2021. The money will go toward clinical trials,…
English 
Spanish 
French 
Portuguese